MBA Advisors’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$400K Buy
7,346
+458
+7% +$26.6K 0.13% 107
2026
Q2
$425K Buy
6,888
+38
+0.6% +$2.29K 0.14% 100
2026
Q1
$401K Hold
6,850
– – 0.15% 96
2025
Q4
$388K Buy
6,850
+531
+8% +$29K 0.16% 98
2025
Q3
$335K Buy
6,319
+242
+4% +$13.1K 0.14% 104
2025
Q2
$288K Buy
6,077
+327
+6% +$14.5K 0.13% 110
2025
Q1
$238K Buy
5,750
+100
+2% +$3.93K 0.12% 122
2024
Q4
$205K Buy
+5,650
New +$204K 0.1% 126

Other funds holding BTI

MBA Advisors's BTI Position: Q3 2026 in Review

MBA Advisors increased its British American Tobacco (BTI) stake by 6.6% in Q3 2026, buying an estimated $26.6K and bringing the position to 7,346 shares worth $400K. The position accounts for 0.13% of the portfolio, ranked #107.

MBA Advisors first reported a position in BTI in Q4 2024 and has held it in 8 quarters since. The position peaked at $425K in Q2 2026. 638 funds tracked by Wall St. Rank hold BTI as of Q3 2026.

  • MBA Advisors held 7,346 shares of British American Tobacco worth $400K as of Q3 2026.
  • MBA Advisors bought 458 British American Tobacco shares in Q3 2026, an estimated $26.6K.
  • British American Tobacco made up 0.13% of MBA Advisors's portfolio in Q3 2026, its #107 holding.
  • MBA Advisors first reported a position in British American Tobacco in Q4 2024 and has held it in 8 quarters since.
  • MBA Advisors's British American Tobacco position peaked at $425K in Q2 2026.
  • 638 funds tracked by Wall St. Rank held British American Tobacco as of Q3 2026.

Based on MBA Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.